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Abstract
Pulmonary emphysema and bronchiectasis in HIV seropositive patients has been described in the
presence of injection drug use, malnutrition, repeated opportunistic infections, such as Pneumocytis
jirovici pneumonia and Mycobacterium tuberculosis infection, and has been linked to the presence of
HIV virus in lung tissue. Given the high burden of pulmonary infections and malnutrition among
people living with HIV in resource poor settings, these individuals may be at increased risk of
developing pulmonary emphysema, potentially reducing the long term benefit of antiretroviral
therapy (ART) if initiated late in the course of HIV infection.
In this report, we describe three HIV-infected individuals (one woman and two children) presenting
with extensive pulmonary cystic disease.
Background
A number of reports from the US and Europe have
described cystic lesions in the lungs of children and adults
infected with the human immunodeficiency virus (HIV)
with or without overt acquired immunodeficiency syn-
drome (AIDS) [1,2]. Pulmonary emphysema, an ana-
tomic alteration of the lung, is characterized by abnormal
enlargement of the air spaces distal to the terminal bron-
chiole, with destruction of their walls and without obvi-
ous fibrosis. In industrialized countries, a 15 to 42%
prevalence of HIV related pulmonary emphysema has
been observed in small case series, much higher than the
estimated 1.8% prevalence in the general population [1].
Bronchiectasis is defined as irreversible dilatation of the
bronchi, usually associated with inflammation. In a
cohort of 164 HIV infected children from New York, the
prevalence of bronchiectasis was estimated at 15% [2].
Little is known about the pulmonary emphysema and
bronchiectasis in people living with HIV from resource
poor settings. We report on three HIV seropositive
patients (one adult and two children) with pulmonary
emphysema seen at the pediatric Hospital Kalembe
Lembe in Kinshasa, Democratic Republic of Congo and
review the literature on HIV-associated pulmonary
emphysema.
Published: 22 September 2007
Journal of Medical Case Reports 2007, 1:101 doi:10.1186/1752-1947-1-101
Received: 4 June 2007
Accepted: 22 September 2007
This article is available from: http://www.jmedicalcasereports.com/content/1/1/101
© 2007 Callens et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 5
(page number not for citation purposes)
Journal of Medical Case Reports 2007, 1:101 http://www.jmedicalcasereports.com/content/1/1/101Case presentation
Case 1
A 39-year old HIV seropositive woman, with a medical
history of recurrent oral ulcerations, thoracic Herpes zoster,
weight loss, caries, repeated pneumonia and three epi-
sodes of smear positive tuberculosis (1990, 2001 and
2003), presented in our clinic in May 2005 with chronic
productive cough and intermittent hemoptysis. Her fam-
ily history did not reveal any hereditary lung diseases. She
had never smoked or used intravenous drugs. She received
cotrimoxazole prophylaxis but had never had access to
ART.
Clinical exam revealed a normal respiratory and cardiac
rate, weight 47.3 kg and height 159 cm (body mass index;
BMI: 18.7), pallor, lesions of an old zona eruption on the
left shoulder, oral ulcerations and caries. Lung ausculta-
tion revealed discrete crepitations in both lung fields. The
CD4+ T lymphocyte count was 329 cells/mm3.
A sputum specimen was negative for acid fast bacilli.
Gram stain showed a large number of epithelial and poly-
nuclear cells, gram negative bacilli and gram positive
cocci. Sputum culture grew Klebsiella pneumoniae, sensitive
to nalidixic acid, norfloxacin, ciprofloxacin, cefotaxime
and gentamycin. Chest X-ray (Figure 1) was compatible
with surinfected dystrophic bullous emphysema and a
small right-sided pleural effusion.
The patient was treated with seven days of clindamycin,
followed by one week of amoxicillin/clavulanic acid, with
good clinical response. ART (stavudine, lamivudine, nevi-
rapine) was initiated, based on WHO stage III clinical dis-
ease. Because hemoptysis persisted and pulmonary
infiltrates increased, treatment with fluconazole for pre-
sumptive fungal surinfection was started 2 weeks after ini-
tiation of ART with resolution of symptoms and signs.
Case 2
A 4 year old HIV seropositive girl, with a history of oral
ulcerations, presented at our clinic in April 2005. She was
on cotrimoxazole prophylaxis, but never had access to
ART. On the first visit, she presented with diarrhea, cough
and rhinorrhea. She was severely malnourished, with dis-
colored hair and distended abdomen, body weight was 8
kg for 91 cm (BMI: 9.7). Clinical exam revealed normal
cardiac frequency (90 beats/min), a borderline respiratory
rate (40 cycles/min), bilateral ronchi, drumstick fingers
and generalized lymphadenopathy.
CD4+ T lymphocyte percent was 3.5% and CD4+ T lym-
phocyte count 92 cells/mm3. She was initially treated oral
clindamycin and subsequently with intramuscular ceftri-
axone, oral salbutamol, prednisolone and quinine, with
good clinical response. The child started ART (stavudine,
lamivudine, nevirapine) in May 2005.
In June 2005, after bathing in a river, she developed severe
dyspnea, persistent cough, vomiting and fever. Clinical
exam revealed a fever (38.7°C), tachypnea (80 cycles/
min) and tachycardia (170 beats/min). Lung auscultation
revealed crepitations, ronchi and wheezing. She was
treated for possible aspiration pneumonia with ceftriax-
one and gentamycin, hydrocortisone, acetaminophen,
and salbutamol.
In July 2005, the child presented with cough, dyspnea and
fever. There was tachypnea (56 cycles/min), tachycardia
(140 beats/min) and tubar sound on auscultation. Chest
X-ray (Figure 2) showed a pyopneumothorax in an exten-
sive bulla on the upper right side and the child was started
on clindamycin and gentamycin. The pyopneumothorax
resolved, but the cough and fever remained. The child was
started on ipratropium and budesonide inhalation,
antituberculous treatment and nutritional rehabilitation.
One month later, she was asymptomatic and the bulla
had dramatically reduced in size.
Case 3
A 13 year old HIV seropositive child presented in our
clinic in June 2005, with a history of persistent ductus
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prurigo and pulmonary tuberculosis,. She was on co-tri-
moxazole prophylaxis but had never had access to ART.
Clinical exam revealed a body weight of 19 kg for a height
of 122 cm (BMI: 12.8), an umbilical hernia and prurigo.
The CD4+ lymphocyte percentage was 12%, absolute
CD4+ T lymphocyte count was 356 cells/mm3. ART (stavu-
dine, lamivudine, nevirapine) was started in July 2005.
In August 2005, she complained of nocturnal fever and
transpiration since 7 days, epistaxis, anorexia, a produc-
tive cough and mucopurulent sputa for 2 weeks. The clin-
ical exam revealed a normal respiratory rate (28 cycles/
min), a cardiac rate of 92 beats/min, seborrheic dermati-
tis, cheilitis and ronchi most pronounced at the base of
the right lung. A thick smear was negative; white blood
cell count was 17.600 cells/mm3 with 48% neutrophils
and 52% lymphocytes. Sputum smear examination was
negative for acid fast stain, gram stain showed epithelial
cells, polynuclear cells, yeast buds, and Candida albicans
growth in sputum culture. Amoxicillin, quinine, flucona-
zole and multivitamin were prescribed. Two weeks later,
the child returned because of persistent cough and fever.
Clinical exam showed a fever (39°C), a normal respira-
tory rate (25 cycles/min) and bilateral ronchi on ausculta-
tion. Chest X ray (Figure 3) showed an alveo-interstitial
infiltrate in the right lower lung field and multiple bullae
spread throughout the right lung.
Early September 2005, the girl died due to complicated
measles infection.
Discussion
We report three cases of pulmonary cystic disease in HIV
positive individuals with multiple risk factors for the
development of emphysema.
Although emphysema and bronchiectasis are defined by
histopathological exam of lung biopsies, a diagnosis can
be inferred based on chest X-ray, pulmonary function
tests, and high resolution computed tomography (HRCT).
In the absence of HRCT, as was the case in our centre, the
exact diagnosis might be difficult to establish. Emphy-
sema is only consistently diagnosed on chest X-ray when
the disease is severe, diagnosed in about half the instances
when the disease is of moderate severity and almost con-
sistently missed in mild cases [3]. Moreover, bullae reflect
only locally severe disease and are not necessarily indica-
tive of widespread emphysema. Bullae on conventional
chest X-ray present as radiolucent areas larger than one
centimeter in diameter surrounded by arcuate hairline
shadows. In bronchiectasis, findings may be nonspecific
and include focal pneumonitis, scattered irregular opaci-
ties, linear or plate-like atelectasis, or specifically dilated
and thickened airways that appear as ring-like shadows or
tram lines [4].
Several potential risk factors, such as intravenous drug
use, repeated pulmonary infections, malnutrition and
HIV infection itself have been described, but no rigorous
case control studies have been published.
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been associated with the development of talcosis and sub-
sequently emphysema and bulla formation. Intravenous
illicit drug use, methylphenidate in particular, has been
linked to the development of a specific pattern of lower-
lobe emphysema, resembling panacinar emphysema due
to α1-protease inhibitor deficiency [5].
Recurrent infections, especially Pneumocystis jiroveci, have
been associated with emphysematous changes and bron-
chiectasis in patients with HIV infection [2]. Conversely,
while tuberculosis is one of the most prevalent opportun-
istic infections in people living with HIV in resource poor
settings, the association with emphysema and bron-
chiectasis has not been studied widely in this population
[6].
Emphysema may also be a direct effect of the HIV virus.
Reported by Diaz et al, four HIV infected patients without
history of pneumonia, other pulmonary opportunistic
infections or other known causes of emphysema, showed
a markedly abnormal pulmonary function with air-trap-
ping, hyperinflation, decreased diffusing capacity and
emphysema-like bullous changes on HRCT [7]. In one
autopsy study of AIDS patients, infection of macrophages
by the HIV virus resulted in the upregulation of matrix
metalloproteases in neighboring uninfected macrophages
and was strongly associated with loss of alveolar wall [8].
Lymphoid interstitial pneumonitis (LIP) has been sug-
gested as an etiologic factor for bronchiectasis and bullae
in HIV positive patients. Two patients with transbronchial
biopsy evidence of LIP but no antecedent histories of
infection have been reported to have CT-proven bron-
chiectasis [9]. One case report described extensive bullae
in the course of LIP [10].
Malnutrition and weight loss, common complications of
HIV infection in resource poor settings, may affect human
lung structure and function, as reported in starvation [11].
While some authors argue that some of these changes may
be reversible, the chronic catabolic state in HIV infection
and insufficient calorie intake in sub Saharan Africa may
lead to irreversible lung damage and chronic pulmonary
disease [11]. Furthermore, malnutrition increases the risk
of infections in general [12].
Treatment options for emphysema and bronchiectasis are
focused on symptom control, treatment of disease exacer-
bation and attempts to limit the rate of disease progres-
sion. In the absence of lung function tests, the assessment
of clinical improvement following medical intervention
will be limited and rely solely on patient history. Medical
interventions include smoking cessation, bronchodila-
tors, oxygen supplementation, and management of exac-
erbations with antibiotics [13]. HIV positive patients
should also be offered cotrimoxazole prophylaxis, isoni-
azid preventive therapy, and could benefit from vaccina-
tion against Haemophilus influenzae and Streptococcus
pneumonia [14]. Given the direct cytotoxic effect of HIV
infection, inhibition of HIV replication at the lung com-
partment through ART may further modulate the disease
[8]. It remains however, unclear if ART should be consid-
ered in all HIV infected patients with proven emphysema
or bronchiectasis, independent of CD4 count and clinical
staging.
The commonest indication for surgical bullectomy is
severe dyspnea in the setting of a large bulla occupying at
least 30 percent of the hemi thorax. Although, lung vol-
ume reduction surgery improves survival compared to
conservative therapy, it should be reserved for patients
with upper-lobe-predominant emphysema in well-
equipped and experienced treatment centers [15].
Conclusion
A high (15 to 42%) prevalence of emphysema and bron-
chiectasis among people living with HIV has been
reported in industrialized countries, but no data is availa-
ble form resource poor settings. Given the high incidence
of pulmonary infections and malnutrition, HIV positive
persons in resource poor settings are at an even higher risk
of developing pulmonary emphysema and cystic disease.
Chronic pulmonary disease, including emphysema and
bronchiectasis, might become an increasingly important
HIV associated co-morbidity. Due to the irreversible and
progressive nature of the chronic lung disease, these pul-
monary complications could compromise the benefits of
expanding access to ART in resource poor settings.
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